Literature DB >> 21122534

Pulmonary manifestations of inflammatory bowel disease: case presentations and review.

Benjamin Basseri1, Pedram Enayati, Alberto Marchevsky, Konstantinos A Papadakis.   

Abstract

Inflammatory bowel disease (IBD) is associated with a number of extraintestinal manifestations that may involve most organ systems. Extraintestinal manifestations are more common in Crohn disease (CD) and may include rheumatologic, ocular, dermatologic, biliary and pulmonary manifestations. The most common pulmonary manifestations of IBD are drug-induced lung disease. Other manifestations include parenchymal disease, pleuritis and overlap syndromes. We present a case series of 7 patients with non-infectious pulmonary manifestations of IBD, which included cryptogenic organizing pneumonia, usual interstitial pneumonitis (UIP), Langerhan's granulomatosis, and eosinophilic pneumonia. Concurrent extraintestinal manifestations present in these patients included arthralgia, iritis, and pyoderma gangrenosum. In most patients the development of pulmonary disease parallels that of the intestinal disease activity, extraintestinal manifestations and concurrent use of 5-ASA medications.
Copyright © 2010 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21122534     DOI: 10.1016/j.crohns.2010.03.008

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  24 in total

Review 1.  Extraintestinal manifestations and complications in IBD.

Authors:  Claudia Ott; Jürgen Schölmerich
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-09       Impact factor: 46.802

2.  Pulmonary involvement: a rare extraintestinal manifestation of ulcerative colitis.

Authors:  Jun Nishikawa; Ayumu Hosokawa; Hiroshi Mihara; Ryuji Hayashi; Shigeharu Miwa; Tatsuhiko Kane; Sohachi Nanjo; Takayuki Ando; Haruka Fujinami; Shinya Kajiura; Masami Minemura; Toshiro Sugiyama
Journal:  Clin J Gastroenterol       Date:  2014-03-13

3.  Organizing pneumonia presenting after ulcerative colitis remission.

Authors:  Eun Chul Jang; Suk Jin Choi; Jae Hwa Cho; Jeong-Seon Ryu; Seung Min Kwak; Hong Lyeol Lee; Hae-Seong Nam
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

Review 4.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Xiao-Qing Ji; Li-Xia Wang; De-Gan Lu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 5.  Pulmonary manifestations of Crohn's disease.

Authors:  De-Gan Lu; Xiao-Qing Ji; Xun Liu; Hong-Jia Li; Cai-Qing Zhang
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

6.  Successful treatment of ulcerative bronchiolitis in a woman with refractory Mycobacterium intracellulare infection.

Authors:  John Patrick Egan; Benjamin J Seides; Kenneth N Olivier; Doreen Addrizzo-Harris
Journal:  BMJ Case Rep       Date:  2015-04-29

Review 7.  Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.

Authors:  Nevins W Todd; Sergei P Atamas; Stella E Hines; Irina G Luzina; Nirav G Shah; Edward J Britt; Andrew J Ghio; Jeffrey R Galvin
Journal:  Expert Rev Respir Med       Date:  2022-01-31       Impact factor: 3.772

8.  Shortness of breath in a patient with inflammatory bowel disease.

Authors:  Aoife Abbey; Amy C Elsmore
Journal:  BMJ Case Rep       Date:  2014-10-09

Review 9.  Probiotics in the management of lung diseases.

Authors:  Esmaeil Mortaz; Ian M Adcock; Gert Folkerts; Peter J Barnes; Arjan Paul Vos; Johan Garssen
Journal:  Mediators Inflamm       Date:  2013-05-08       Impact factor: 4.711

10.  Small intestine inflammation in Roquin-mutant and Roquin-deficient mice.

Authors:  Jeremy S Schaefer; Dina Montufar-Solis; Niyati Nakra; Nadarajah Vigneswaran; John R Klein
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.